Preview Mode Links will not work in preview mode

Clinical Literature Summaries presented by InpharmD™ (S3)


Apr 29, 2022

A regression analysis conducted in Israel showed that a fourth dose appeared to increase the protection against severe illness relative to three doses that were administered more than 4 months earlier. Further studies are needed before applying this to a larger population.